课题基金 / 基金详情

Efficient Facility Feedback of Existing Culture Testing is Able to Mitigate Resistance (EFFECT-AMR)

Efficient Facility Feedback of Existing Culture Testing is Able to Mitigate Resistance (EFFECT-AMR)
现有培养测试的有效设施反馈能够减轻耐药性 (EFFECT-AMR)
批准号：
478247
负责人：
Daneman Nick
金额：
$49.88万
依托单位：
Public Health Ontario (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2026-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=478247&lang=en
关键词：
Acute Care Antibiograms Antimicrobial Resistance Antimicrobial Stewardship Audit-And-Feedback Health Services Research Long Term Care Population-Based Research

项目摘要

项目成果

Daneman Nick的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antimicrobial resistance (AMR) is a global threat to health, and is responsible for more than 1 million attributable deaths per year. Surveillance is a crucial means to control rising AMR rates, and generate pathogen-specific resistance information (anti
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the impact of a SIMPlified LaYered consent process versus a conventional informed consent form on recruitment of potential participants to a large platform clinical trial: a pragmatic nested randomized controlled trial (SIMPLY-SNAP Trial) - Ful
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial
海外基金